[HTML][HTML] Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy: a cross-sectional study
L Pang, AM Zhang, HX Li, JL Du, LL Jiao, N Duan… - Medicine, 2017 - ncbi.nlm.nih.gov
L Pang, AM Zhang, HX Li, JL Du, LL Jiao, N Duan, Y Liu, D Yu
Medicine, 2017•ncbi.nlm.nih.govM-type phospholipase A2 receptor (PLA2R) is the major target antigen in primary
membranous nephropathy (PMN). Previous studies have evaluated the diagnostic value of
serum anti-PLA2R antibody. However, the correlation of serum anti-PLA2R antibody and
glomerular PLA2R deposition, and their association with clinical characteristics need to be
further evaluated.
membranous nephropathy (PMN). Previous studies have evaluated the diagnostic value of
serum anti-PLA2R antibody. However, the correlation of serum anti-PLA2R antibody and
glomerular PLA2R deposition, and their association with clinical characteristics need to be
further evaluated.
Abstract
M-type phospholipase A2 receptor (PLA2R) is the major target antigen in primary membranous nephropathy (PMN). Previous studies have evaluated the diagnostic value of serum anti-PLA2R antibody. However, the correlation of serum anti-PLA2R antibody and glomerular PLA2R deposition, and their association with clinical characteristics need to be further evaluated.
ncbi.nlm.nih.gov
以上显示的是最相近的搜索结果。 查看全部搜索结果